Cure51 raises a €15 million seed round led by Sofinnova Partners to harness the natural power of cancer survivors and contribute to curing the disease.
Amount Raised
€15 Million
Round Type
Seed
ParisBiotechnologyHealth CareMedicalInvestors
Description
Cure51 announced a successful €15 million seed funding round led by Sofinnova Partners. Other investors included Hitachi Ventures GmbH, Life Extension Ventures, Xavier Niel, and Olivier Pomel, CEO, and co-founder of Datadog. The funding will enable Cure51 to build a unique cohort exploring the molecular processes by which certain cancer patients survive for extended periods despite having highly aggressive forms of the disease.
Quick answer
Cure51 raised €15 Million in a Seed round, dated March 20, 2024. Investors: Olivier Pomel, Xavier Niel, Life Extension Ventures, Hitachi Ventures Gmb H and Sofinnova Partners. Cure51 is based in Paris, Ile-de-France, France.
- How much did Cure51 raise?
- Cure51 raised €15 Million in a Seed round on March 20, 2024.
- Who invested in Cure51?
- Olivier Pomel, Xavier Niel, Life Extension Ventures, Hitachi Ventures Gmb H and Sofinnova Partners are named as investors in this round.
- What does Cure51 do?
- Cure51 is a French "TechBio" company founded by Nicolas Wolikow and Simon Istolainen, alongside seasoned entrepreneurs and four world-renowned oncology centers: Gustave Roussy Institute (IGR, Paris - France ), Leon..
- Where is Cure51 based and how big is it?
- Cure51 is based in Paris, Ile-de-France, France.
- Who are the decision-makers at Cure51?
- Fundz holds 1 contact at Cure51. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Biotechnology around the same time
Companies in the same sectors as Cure51 that raised within 45 days of this round, from Fundz verified event records.
- Ikerian raised $6.2M (Series A) on May 2, 2024.
- Scipher Medicine raised $25M on May 2, 2024.
- Novocure raised $400M (Debt Financing) on May 2, 2024.
- Livara Health raised $15M (Series B) on May 2, 2024.
- Streamex Corp. raised $1.1M (Seed) on May 1, 2024.
- PlaqueTec raised $8M on April 30, 2024.
Who to call at Cure51, and when
A new round usually means Cure51 is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cure51 raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cure51, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cure51. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cure51 raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cure51 raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.